Cargando…
Reuse of Molecules for Glioblastoma Therapy
Glioblastoma multiforme (GBM) is a highly malignant primary brain tumor. The current standard of care for GBM is the Stupp protocol which includes surgical resection, followed by radiotherapy concomitant with the DNA alkylator temozolomide; however, survival under this treatment regimen is an abysma...
Autores principales: | Koehler, Abigail, Karve, Aniruddha, Desai, Pankaj, Arbiser, Jack, Plas, David R., Qi, Xiaoyang, Read, Renee D., Sasaki, Atsuo T., Gawali, Vaibhavkumar S., Toukam, Donatien K., Bhattacharya, Debanjan, Kallay, Laura, Pomeranz Krummel, Daniel A., Sengupta, Soma |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7912673/ https://www.ncbi.nlm.nih.gov/pubmed/33525329 http://dx.doi.org/10.3390/ph14020099 |
Ejemplares similares
-
Advances in Immunotherapy for the Treatment of Adult Glioblastoma: Overcoming Chemical and Physical Barriers
por: Lechpammer, Mirna, et al.
Publicado: (2022) -
Ligand-Gated Ion Channels as Targets for Treatment and Management of Cancers
por: Rao, Rohan, et al.
Publicado: (2022) -
Pediatric cerebellar tumors: transcriptionally distinct but developmentally heterogeneous
por: Bhattacharya, Debanjan, et al.
Publicado: (2020) -
The evolution of medulloblastoma therapy to personalized
medicine
por: Sengupta, Soma, et al.
Publicado: (2017) -
20. MELANOMA CELL INTRINSIC GABAA RECEPTOR ENHANCEMENT POTENTIATES RADIATION AND IMMUNE CHECKPOINT INHIBITOR RESPONSE BY PROMOTING DIRECT AND T CELL-MEDIATED ANTI-TUMOR ACTIVITY
por: Sengupta, Soma, et al.
Publicado: (2020)